PBI News

Press Releases
Pacific Biometrics Inc. Reports First Quarter Operating Results
Complete press release

PBI Published
Effects of Atorvastatin on Bone in Postmenopausal Women with Dyslipidemia: A Double-Blind, Placebo-Controlled, Dose-Ranging Trial
Click here for the complete article.

Stock Quote
PBI Listed
OTCBB: PBME

PBI on the road
Meet us at our next conference:
AAPS Annual Meeting
November 16-20, 2008
Atlanta, GA

To learn more about the
event click here.

The Value of Expertise

PBI has the best available methods and technologies, including in some cases, CDC reference assays. These provide unsurpassed quality and accuracy for clinical research. Since 1989 , PBI has supported hundreds of clinical trials for many major pharmaceutical, diagnostic, and biotechnology companies.

Specialty Central Laboratory: Leader in Setting Industry Standards

PBI provides comprehensive laboratory support for pharmaceutical and diagnostic product research. PBI has established a world-wide reputation for expertise in lipid and bone biomarkers as well as diabetes, arthritis, and inflammatory assessments. PBI is actively involved in researching, developing, and standardizing key assays for chronic diseases.

Immunogenicity and Clinical Biomarker Testing

PBI is launching a new area of specialty testing services for clinical drug development. Designed primarily to support clinical development of biotherapeutics, the new services will include validation of ligand-binding assays for immunogenicity testing and novel biomarkers in a regulatory-compliant laboratory environment.